Literature DB >> 31049594

Subclassifying ANCA-associated vasculitis: a unifying view of disease spectrum.

Alfred Mahr1, Ulrich Specks2, David Jayne3.   

Abstract

Entities:  

Year:  2019        PMID： 31049594     DOI： 10.1093/rheumatology/kez148

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  6 in total

1.  Treatment of Granulomatosis with Polyangiitis and Microscopic Polyangiitis: Should Type of ANCA Guide the Treatment?

Authors:  Vladimir Tesar; Zdenka Hruskova
Journal:  Clin J Am Soc Nephrol       Date:  2020-05-29       Impact factor: 8.237

2.  Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.

Authors:  Sun Moon Kim; Song-Yi Choi; Seon Young Kim; Jinhyun Kim
Journal:  Rheumatol Int       Date:  2019-09-24       Impact factor: 2.631

3.  The alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis.

Authors:  S Moiseev; J M Lee; A Zykova; N Bulanov; P Novikov; E Gitel; M Bulanova; E Safonova; J I Shin; A Kronbichler; D R W Jayne
Journal:  Clin Exp Immunol       Date:  2020-09-15       Impact factor: 4.330

Review 4.  [Radiologic Approach for Pulmonary Vasculitis].

Authors:  Chohee Kim; Yoon Kyung Kim; Joungho Han
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-07-02

Review 5.  Proposal for a more practical classification of antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Nestor Oliva-Damaso; Andrew S Bomback
Journal:  Clin Kidney J       Date:  2020-12-29

6.  Neutrophil Extracellular Traps Induce Tissue-Invasive Monocytes in Granulomatosis With Polyangiitis.

Authors:  Mitsuhiro Akiyama; Markus Zeisbrich; Nour Ibrahim; Shozo Ohtsuki; Gerald J Berry; Peter H Hwang; Jörg J Goronzy; Cornelia M Weyand
Journal:  Front Immunol       Date:  2019-11-13       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.